These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22430729)

  • 1. Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis.
    Kang Y; Dong X; Zhou Q; Zhang Y; Cheng Y; Hu R; Su C; Jin H; Liu X; Ma D; Tian W; Li X
    Prenat Diagn; 2012 Mar; 32(3):284-92. PubMed ID: 22430729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.
    Nagalla SR; Canick JA; Jacob T; Schneider KA; Reddy AP; Thomas A; Dasari S; Lu X; Lapidus JA; Lambert-Messerlian GM; Gravett MG; Roberts CT; Luthy D; Malone FD; D'Alton ME
    J Proteome Res; 2007 Apr; 6(4):1245-57. PubMed ID: 17373838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary proteomic-based identification of a novel protein for Down's syndrome in maternal serum.
    Yu B; Zhang B; Wang J; Wang QW; Huang RP; Yang YQ; Shao SH
    Exp Biol Med (Maywood); 2012 May; 237(5):530-9. PubMed ID: 22678011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma.
    Kolialexi A; Tsangaris GT; Papantoniou N; Anagnostopoulos AK; Vougas K; Bagiokos V; Antsaklis A; Mavrou A
    Prenat Diagn; 2008 Aug; 28(8):691-8. PubMed ID: 18551720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bead-based multiplexed immunoassays to identify new biomarkers in maternal serum to improve first trimester Down syndrome screening.
    Koster MP; Pennings JL; Imholz S; Rodenburg W; Visser GH; de Vries A; Schielen PC
    Prenat Diagn; 2009 Sep; 29(9):857-62. PubMed ID: 19488973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are serum protein biomarkers derived from proteomic analysis useful in screening for trisomy 21 at 11-13 weeks?
    Mastricci AL; Akolekar R; Kuppusamy R; Ahmed M; Nicolaides KH
    Fetal Diagn Ther; 2011; 30(1):53-9. PubMed ID: 21422752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of free fetal DNA with beta-human chorionin gonadotropin in circulation in pregnant women with high risk of Down's syndrome].
    Meng JL; Wang XT; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):661-4. PubMed ID: 20079176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
    Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
    J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteomic analysis of down syndrome biomarkers in maternal serum using isobaric tags for relative and absolute quantification (iTRAQ).
    Zhao SL; Liu XW; Wu SW; Zheng YY; Zhang WY
    Gynecol Endocrinol; 2020 Jun; 36(6):489-495. PubMed ID: 31793358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester maternal serum progesterone in aneuploid pregnancies.
    Christiansen M; Sørensen TL; Larsen SO; Nørgaard-Pedersen B
    Prenat Diagn; 2008 Apr; 28(4):319-22. PubMed ID: 18317998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and identification of potential predictive biomarkers for Down's syndrome from second trimester maternal serum.
    Yao Y; Jiang Y; Han M; Xia Y; He Y; Wang Y; Luo Y; Zhang B
    Expert Rev Proteomics; 2015 Feb; 12(1):97-107. PubMed ID: 25434962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
    Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
    Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking.
    Bortner JD; Richie JP; Das A; Liao J; Umstead TM; Stanley A; Stanley BA; Belani CP; El-Bayoumy K
    J Proteome Res; 2011 Mar; 10(3):1151-9. PubMed ID: 21186835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum leptin in first-trimester Down syndrome pregnancies.
    Hedley P; Christiansen M
    Prenat Diagn; 2008 Jun; 28(6):475-7. PubMed ID: 18437707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum screening of pregnant women reveals Down syndrome. Analysis of biochemical markers for earlier detection].
    Christiansen M; Larsen SO; Nørgaard-Pedersen B
    Lakartidningen; 1997 Dec; 94(51-52):4898-902. PubMed ID: 9454010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human placental lactogen is a first-trimester maternal serum marker of Down syndrome.
    Christiansen M; Sørensen TL; Nørgaard-Pedersen B
    Prenat Diagn; 2007 Jan; 27(1):1-5. PubMed ID: 17154235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal plasma levels of follistatin-related gene protein in the first trimester of pregnancies with Down syndrome.
    Miron P; Lambert J; Marcil A; Cowans NJ; Stamatopoulou A; Spencer K
    Prenat Diagn; 2010 Mar; 30(3):224-8. PubMed ID: 20063262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of the alteration of protein expression in the placenta of Down syndrome.
    Sun CJ; Yan LY; Wang W; Yu S; Wang X; Zhang WY
    Chin Med J (Engl); 2011 Nov; 124(22):3738-45. PubMed ID: 22340234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.